Drugs / MRT5429
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06361875 | Apr 2024 → Jun 2025 | — | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MRT5429 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06361875 ↗ |
| Route | Intramuscular | “Route of administration:Intramuscular Injection” NCT06361875 ↗ |